Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1640266 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $3.41 · Day +3.33% · Mkt cap $203M · 1Y −4.2% · Off 52W high −38.6% · Vol (1Y) 61.0% Price2023-08-21 → 2026-08-19 VYGR close: $9.4 on 2023-08-21 to $3.4 on 2026-08-19. Split-adj closes · 240 of 2,705 · price returnⓘ At a glance | Short interest5.9% of sh out | | Days to cover5.8d | | 13F net flow (QoQ)+4.31% | | Top-10 13F concentration68.3% | | Next report (est.)2026-11-06 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$34.8M | | Earnings (TTM)-$107.7M | | ROE−48.3% | | Net margin−296.5% | | ROIC−58.0% | | Sales growth 3Y−1.5% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−13.2% | | 1Y−4.2% | | 3Y−63.7% | | 5Y+20.5% | | 10Y−77.8% | | Since incept. (ann.)−14.2% |
Total return · from 2015-11-11ⓘ Risk | Ann. volatility (1Y)61.0% | | Ann. volatility (3Y)64.8% | | Sharpe (1Y)0.10 | | Sharpe (3Y)−0.20 | | Max drawdown (1Y)−43.7% | | Max drawdown (3Y)−74.8% | | Beta (3Y vs SPY)1.64 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 5.6M | $21M | 9.34% | −0.9% | | ARMISTICE CAPITAL, LLC | 3.5M | $14M | 5.87% | −12.5% | | MILLENNIUM MANAGEMENT LLC | 3.4M | $13M | 5.75% | +82.3% | | Vestal Point Capital, LP | 3.0M | $12M | 5.04% | +103.6% | | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $9M | 3.83% | new | | Opaleye Management Inc. | 1.1M | $4M | 1.93% | −3.9% | | Erste Asset Management GmbH | 1.1M | $4M | 1.84% | −8.4% | | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $4M | 1.76% | −7.5% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | −$0.40 | — | $3.2M | −42.5% | | 2026-03-31 | 2026-05-07 | −$0.47 | — | $2.6M | −62.5% | | 2025-12-31 | 2026-03-09 | — | — | $15.3M | +144.3% | | 2025-09-30 | 2025-11-10 | −$0.47 | — | $13.7M | −44.9% |
As-reported XBRL · next 2026-11-06 est.ⓘ Segment mixFY2025 (ended Dec 2025) Single Reportable 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
